Supplementary Table S4 from Genomic Profiling Reveals SMARCA4 Mutations Are Associated with Shorter Overall and Intracranial Progression-Free Survival in Patients with Melanoma Brain Metastases
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S4. MSK-IMPACT primary tumor samples used in analyses, information on if brain metastases ever developed in patients, and survival information from the time of melanoma diagnosis.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4407629212
